University of Pittsburgh PITT HOME  |  FIND PEOPLE  |  CONTACT US  
 
Health Sciences @ Pitt   |    UPMC   |    HSLS   |    School of Medicine   |    Health Sciences Calendar   |    Our News & Events  
 
HOME
ABOUT US
FACULTY
CLINICAL TRAINEES
RESEARCH TRAINEES
ATTENTION ALUMNI
RESIDENCY PROGRAM
RESIDENT WEBSITE
CONFERENCES
EVENTS
CORNEA FELLOWSHIP PROGRAM
GLAUCOMA FELLOWSHIP PROGRAM
NEURO-OPHTHALMOLOGY FELLOWSHIP PROGRAM
ORBITAL, OCULOPLASTICS AND AESTHETIC SURGERY FELLOWSHIP
PEDIATRIC OPHTHALMOLOGY FELLOWSHIP PROGRAM
RETINA FELLOWSHIP PROGRAM
CLINICAL RESOURCES
VISUAL DIAGNOSTICS, IMAGING & LASERS
OPHTHALMOLOGY RESEARCH
RESEARCH LABORATORIES
CORE RESEARCH FACILITIES
GIVING & DEVELOPMENT
LECTURE SCHEDULE
LINKS
EMPLOYMENT OPPORTUNITIES
NEWS & AWARDS
Faculty
divider bar
 
46mckenna.jpg Kyle C. McKenna, PhD
Assistant Professor of Ophthalmology
Ocular Tumor Immunology Laboratory
University of Pittsburgh School of Medicine

Eye & Ear Institute
203 Lothrop Street, Room 910
Pittsburgh, PA 15213
Phone: 412-802-8437
Email: mckennakc@upmc.edu
Fax: 412.647.5880
Faculty Research Interests
Personal Web Page
 
bullet point  Research Interests
a dividing bar
Ocular Tumor Immunology Laboratory

 
bullet point  Education
a dividing bar
B.S. with honors in Biology University of Maryland, College Park (1991)

Ph. D.- University of Maryland, Baltimore (1999)

Post-doc- Emory University (1999-2003)
 
bullet point  Academic Affiliation
a dividing bar
Assistant Professor, Department of Ophthalmology, School of Medicine, University of Pittsburgh

Assistant Professor, Department of Immunology, School of Medicine,
University of Pittsburgh

Member, University of Pittsburgh Cancer Institute, Cancer Immunology and Immunotherapy Section
 
bullet point  Publications
a dividing bar
1.McKenna, K. C., R. D. Vicetti Miguel, K. M. Beatty, and R. A. Bilonick. 2011. A caveat for T cell transfer studies: generation of cytotoxice anti-Thy 1.2 antibodies in Thy 1.1 congenic mice given Thy 1.2+ tumors or T cells. J. Leuk. Biol. In press.

2.Vicetti Miguel, R. D., T. L. Cherpes, L. J. Watson, and K. C. McKenna. 2010. CTL Induction of Tumoricidal Nitric Oxide Production by Intratumoral Macrophages Is Critical for Tumor Elimination. J. Immunol. 185:6706:6718.

3.McKenna, K. C., and P. W. Chen. 2010. Influence of immune privilege on
ocular tumor development. Ocul. Immunol. Inflamm. 18:80-90.

4.McKenna, K. C., K. M. Beatty, R. A. Bilonick, and A. D. Singh. 2009. Activated
CD11b+ CD15+ Granulocytes Increase in Blood of Uveal Melanoma Patients.
Invest. Ophthalmol. Vis. Sci. 50:4295-4303.

5.McKenna, K. C., K. M. Beatty, R. D. Vicetti Miguel, and R. A. Bilonick. 2009.
Delayed processing of blood increases the frequency of activated CD11b+
CD15+ granulocytes which inhibit T cell function. J. Immunol. Meth. 341:68-75.

6.McKenna, K. C. and J. A. Kapp. 2006. Accumulation of immunosuppressive
CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the
anterior chamber of the eye. J. Immunol. 177:1599.
 
bullet point  Grants
a dividing bar
Title: Mechanisms of Immune Evasion by Ocular Tumors
Agency: NIH/ NEI
Role: PI
Funding Period: 2008-2013

Title: Nanoparticles as OCT Contrast Agent
Agency: NIH/NEI
Role: PI
Funding Period: 2009-2011
 
 
  Top of page  |  Home  |  Contact Us Last Update 9/18/2014  
  Office of the Senior Vice Chancellor for the Health Sciences, University of Pittsburgh. All rights reserved.